These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. Weiss AS; Gallin JI; Kaplan AP J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577 [TBL] [Abstract][Full Text] [Related]
5. Prekallikrein deficiency in a family of miniature horses. Turrentine MA; Sculley PW; Green EM; Johnson GS Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551 [TBL] [Abstract][Full Text] [Related]
6. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation. Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452 [TBL] [Abstract][Full Text] [Related]
8. Mechanized assay of plasma prekallikrein by activation with Pseudomonas aeruginosa elastase and amidolysis of chromogenic substrate. Shibuya Y; Yamamoto T; Tanaka H; Semba U; Kambara T; Okabe H Clin Chim Acta; 1991 Aug; 200(2-3):119-27. PubMed ID: 1777962 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material. Saito H; Goodnough LT; Soria J; Soria C; Aznar J; España F N Engl J Med; 1981 Oct; 305(16):910-4. PubMed ID: 6792540 [TBL] [Abstract][Full Text] [Related]
10. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities. Patrassi GM; Martinelli S; Vianello C; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):644-54. PubMed ID: 6184289 [TBL] [Abstract][Full Text] [Related]
11. Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: role of Factor XI. Nielsen VG Acta Anaesthesiol Scand; 2006 Feb; 50(2):168-72. PubMed ID: 16430537 [TBL] [Abstract][Full Text] [Related]
14. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa). Alving BM; Tankersley DL; Mason BL J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773 [TBL] [Abstract][Full Text] [Related]
15. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. Scicli AG; Mindroiu T; Scicli G; Carretero OA J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569 [TBL] [Abstract][Full Text] [Related]
16. Augmented release of human leucocyte lactoferrin (and elastase) during coagulation. Adeyemi EO; Hodgson HJ J Clin Lab Immunol; 1988 Sep; 27(1):1-4. PubMed ID: 3266944 [TBL] [Abstract][Full Text] [Related]
17. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI. Mitropoulos KA Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760 [TBL] [Abstract][Full Text] [Related]
20. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat. Gáti T; Budavári I; Szombath D; Losonczy G Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]